PPARG and colorectal cancer: PPARγ is highly expressed in both normal intestinal epithelial cells and colorectal cancer cells [113], and PPARγ agonist including thiazolidinedione is demonstrated to be capable of inducing cell apoptosis and differentiation [114] and inhibiting carcinogenesis of normal colonic cells and colon aberrant crypt foci as well [115].